6CM
PHGE icon

683 Capital Management’s BiomX PHGE Stock Holding History

683 Capital Management’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-721
Closed -$1.39M – 178
2019
Q3 		$1.39M Sell
721
-68
-9% -$133K 0.15% 72
2019
Q2 		$1.47M Hold
789
– – 0.13% 89
2019
Q1 		$1.47M Buy
+789
New +$1.47M 0.13% 83

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

683 Capital Management's PHGE Position: Q4 2019 in Review

683 Capital Management sold out of BiomX (PHGE) in Q4 2019, closing a stake of 721 shares — an estimated $1.39M sold.

683 Capital Management first reported a position in PHGE in Q1 2019 and held it in 3 quarters. The position peaked at $1.47M in Q2 2019. 7 funds tracked by Wall St. Rank hold PHGE as of Q4 2019.

  • 683 Capital Management reported no remaining BiomX position as of Q4 2019 after selling out during the quarter.
  • 683 Capital Management sold 721 BiomX shares in Q4 2019, an estimated $1.39M.
  • 683 Capital Management first reported a position in BiomX in Q1 2019 and held it in 3 quarters.
  • 683 Capital Management's BiomX position peaked at $1.47M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held BiomX as of Q4 2019.

Based on 683 Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.